SCHEMBL16570197

SCHEMBL16570197

c1cnc2c(Cn3ccc4cnc(Nc5ccc(N6CCNCC6)cc5)nc43)cccc2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT6 P42226 10/20 0.64
▸ JAK3 P52333 3/20 0.49
▸ JAK2 O60674 2/20 0.49
▸ BRD4 O60885 2/20 0.49
▸ JAK1 P23458 2/20 0.49
▸ BRD2 P25440 2/20 0.49
▸ BRD3 Q15059 2/20 0.49
▸ BRDT Q58F21 2/20 0.49
▸ CDK4 P11802 7/20 0.49
▸ CDK6 Q00534 2/20 0.49
▸ CCNA2 P20248 4/20 0.49
▸ CCND1 P24385 4/20 0.49
▸ CDK2 P24941 4/20 0.49
▸ FGFR1 P11362 3/20 0.47
▸ FGFR2 P21802 3/20 0.47
▸ FGFR4 P22455 3/20 0.47
▸ FGFR3 P22607 3/20 0.47
▸ CCNE2 O96020 1/20 0.47
▸ CCNE1 P24864 1/20 0.47
▸ CCND2 P30279 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16580815 0.84 STAT6 (0.61) STAT6JAK3JAK2BRD4JAK1
SCHEMBL16571213 0.83 STAT6 (0.58) STAT6JAK3JAK2BRD4JAK1
SCHEMBL16570535 0.82 STAT6 (0.57) STAT6JAK3JAK2BRD4JAK1
SCHEMBL16570316 0.82 JAK2 (0.62) STAT6JAK3JAK2BRD4JAK1
SCHEMBL16570585 0.82 STAT6 (0.57) STAT6JAK3JAK2BRD4JAK1
Hydrochloric Acid SCHEMBL16570093 0.81 STAT6 (0.56) STAT6JAK3JAK2BRD4JAK1
SCHEMBL16571340 0.81 STAT6 (0.62) STAT6JAK3JAK2BRD4JAK1
SCHEMBL16570789 0.81 STAT6 (0.55) STAT6JAK3JAK2BRD4JAK1
SCHEMBL16580996 0.80 STAT6 (0.61) STAT6JAK3JAK2BRD4JAK1
SCHEMBL16570901 0.80 STAT6 (0.63) STAT6JAK3JAK2BRD4JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160222014-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2016-08-04 — — US claimed
WO-2015038417-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2015-03-19 — — WO claimed
US-20160222014-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2016-08-04 — — US disclosed
WO-2015038417-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS ASANA BIOSCIENCES, LLC (US) 2015-03-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160222014-A1 COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS SRC, PTK2, FYN STAT6 103/4885JAK3 124/4885JAK2 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback